BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8839376)

  • 1. Update on lung cancer.
    Pierce R; Irving L; Barter C
    Aust Fam Physician; 1996 Feb; 25(2):177-9, 181, 184-8. PubMed ID: 8839376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in non-small cell lung cancer.
    Walker S
    Clin J Oncol Nurs; 2008 Aug; 12(4):587-96. PubMed ID: 18676326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update in non-small cell lung cancer.
    Moore T; Ready N
    Med Health R I; 2002 Jan; 85(1):7-9. PubMed ID: 11824158
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer: diagnosis and management.
    Collins LG; Haines C; Perkel R; Enck RE
    Am Fam Physician; 2007 Jan; 75(1):56-63. PubMed ID: 17225705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
    Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of lung cancer symptoms, pathophysiology, and treatment.
    Yoder LH
    Medsurg Nurs; 2006 Aug; 15(4):231-4. PubMed ID: 16999185
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
    Girard N; Mornex F
    Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiology, prognostic factors, staging, and treatment of non-small cell lung cancer].
    André F; Jacot W; Pujol JL; Grunenwald D; Le Chevalier T
    Bull Cancer; 1999 Oct; Suppl 3():17-41. PubMed ID: 10585572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung cancer in women: clinical features and factors related to survival].
    Sen E; Kaya A; Erol S; Savas I; Gonullu U
    Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
    Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
    Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
    Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
    Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and gender differences in lung cancer.
    Stabile LP; Siegfried JM
    J Gend Specif Med; 2003; 6(1):37-48. PubMed ID: 12661176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
    Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
    Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-resectable stage III non-small cell lung cancer].
    Fournel P
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 2):3S43-7. PubMed ID: 15536352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical issues in the management of the patient with small cell lung cancer.
    Govindan R; Ihde DC
    Chest Surg Clin N Am; 1997 Feb; 7(1):167-81. PubMed ID: 9001763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time from finding abnormality on mass-screening to final diagnosis of lung cancer.
    Kanashiki M; Satoh H; Ishikawa H; Yamashita YT; Ohtsuka M; Sekizawa K
    Oncol Rep; 2003; 10(3):649-52. PubMed ID: 12684638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
    Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
    Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for lung cancer.
    Austin JH; Stellman SD; Pearson GD
    N Engl J Med; 2001 Mar; 344(12):935; author reply 936. PubMed ID: 11263429
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular staging and the selection of therapy for non-small cell lung cancer.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.